EB
Emergent Biosolutions Inc
🇩🇪XFRA.ER4GermanyHealthcare
€5.46EURup +0.18 (+3.41%)OpenEnd of day6:04 PM
Price€5.46+0.18 (+3.41%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US29089Q1058
- CUSIP
- Not reported
Company
- Employees
- 900
- Headquarters
- Gaithersburg, United States
- CEO
- Mr. Joseph C. Papa Jr., M.B.A., R.Ph.
Market
- Shares outstanding
- 52.5M
- Market cap
- €286.76M
Highlights
No high and low reported for today's session.
- Market cap
- €286.76M
- EPS LTM
- -$3.37calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $770.2M-9.56%down year on year
- Net income
- -$176.8M-226.74%down year on year
- Gross margin
- 49.4%-11.37%down year on year
- Free cash flow
- $85.9M-44.58%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.